Construction and validation of a prediction model for early recurrence after catheter ablation in patients with persistent atrial fibrillation based on BNP, Ang Ⅱ, homocysteine, MHR, NLR

ObjectiveTo explore the feasibility and clinical value of early recurrence prediction model for persistent atrial fibrillation after catheter ablation based on brain natriuretic peptide (BNP), angiotensin Ⅱ(Ang Ⅱ), homocysteine, monocyte-to-high density lipoprotein cholesterol (MHR) and neutrophil-t...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuning Chen, Guojian Sun, Zhijun Zhu, Farong Shen
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2025.1589351/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850134344874590208
author Yuning Chen
Guojian Sun
Zhijun Zhu
Farong Shen
author_facet Yuning Chen
Guojian Sun
Zhijun Zhu
Farong Shen
author_sort Yuning Chen
collection DOAJ
description ObjectiveTo explore the feasibility and clinical value of early recurrence prediction model for persistent atrial fibrillation after catheter ablation based on brain natriuretic peptide (BNP), angiotensin Ⅱ(Ang Ⅱ), homocysteine, monocyte-to-high density lipoprotein cholesterol (MHR) and neutrophil-to-lymphocyte ratio (NLR).Methods279 patients with persistent atrial fibrillation who underwent catheter ablation in our hospital from January 2022 to December 2024 were divided into training group (n = 195) and verification group (n = 84) according to the ratio of 7:3. The risk factors were screened by univariate and multivariate Logistic regression analysis, and the nomogram model was constructed, and the effectiveness of the model was evaluated in the verification set.ResultsMultivariate Logistic regression analysis showed that diabetes history, elevated BNP, homocysteine, MHR, NLR and Ang Ⅱ were independent risk factors for early postoperative recurrence (P < 0.05). The C-index index of the nomogram model in the training set and the verification set are 0.803 and 0.846, respectively, and the AUC under the ROC curve is 0.802 (95% CI: 0.685–0.918) and 0.855 (95% CI: 0.736–0.973), respectively.ConclusionThe nomogram prediction model can well predict the early recurrence risk of patients with persistent atrial fibrillation after catheter ablation, and provide a reference for clinical individualized treatment, but it needs further verification by large sample and multi-center research.
format Article
id doaj-art-4ac24d9c95b74ef8b4e369e16ee69f1b
institution OA Journals
issn 2297-055X
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj-art-4ac24d9c95b74ef8b4e369e16ee69f1b2025-08-20T02:31:44ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2025-05-011210.3389/fcvm.2025.15893511589351Construction and validation of a prediction model for early recurrence after catheter ablation in patients with persistent atrial fibrillation based on BNP, Ang Ⅱ, homocysteine, MHR, NLRYuning Chen0Guojian Sun1Zhijun Zhu2Farong Shen3Department of Cardiovascular Medicine, Zhejiang Qiushi Cardiovascular Hospital, Hangzhou, ChinaDepartment of Cardiovascular Medicine, Inner Mongolia People’s Hospital, Hohhot, ChinaDepartment of Cardiovascular Medicine, Zhejiang Qiushi Cardiovascular Hospital, Hangzhou, ChinaDepartment of Cardiovascular Medicine, Zhejiang Qiushi Cardiovascular Hospital, Hangzhou, ChinaObjectiveTo explore the feasibility and clinical value of early recurrence prediction model for persistent atrial fibrillation after catheter ablation based on brain natriuretic peptide (BNP), angiotensin Ⅱ(Ang Ⅱ), homocysteine, monocyte-to-high density lipoprotein cholesterol (MHR) and neutrophil-to-lymphocyte ratio (NLR).Methods279 patients with persistent atrial fibrillation who underwent catheter ablation in our hospital from January 2022 to December 2024 were divided into training group (n = 195) and verification group (n = 84) according to the ratio of 7:3. The risk factors were screened by univariate and multivariate Logistic regression analysis, and the nomogram model was constructed, and the effectiveness of the model was evaluated in the verification set.ResultsMultivariate Logistic regression analysis showed that diabetes history, elevated BNP, homocysteine, MHR, NLR and Ang Ⅱ were independent risk factors for early postoperative recurrence (P < 0.05). The C-index index of the nomogram model in the training set and the verification set are 0.803 and 0.846, respectively, and the AUC under the ROC curve is 0.802 (95% CI: 0.685–0.918) and 0.855 (95% CI: 0.736–0.973), respectively.ConclusionThe nomogram prediction model can well predict the early recurrence risk of patients with persistent atrial fibrillation after catheter ablation, and provide a reference for clinical individualized treatment, but it needs further verification by large sample and multi-center research.https://www.frontiersin.org/articles/10.3389/fcvm.2025.1589351/fullpersistent atrial fibrillationcatheter ablationearly recurrenceprediction modelsserum indicators
spellingShingle Yuning Chen
Guojian Sun
Zhijun Zhu
Farong Shen
Construction and validation of a prediction model for early recurrence after catheter ablation in patients with persistent atrial fibrillation based on BNP, Ang Ⅱ, homocysteine, MHR, NLR
Frontiers in Cardiovascular Medicine
persistent atrial fibrillation
catheter ablation
early recurrence
prediction models
serum indicators
title Construction and validation of a prediction model for early recurrence after catheter ablation in patients with persistent atrial fibrillation based on BNP, Ang Ⅱ, homocysteine, MHR, NLR
title_full Construction and validation of a prediction model for early recurrence after catheter ablation in patients with persistent atrial fibrillation based on BNP, Ang Ⅱ, homocysteine, MHR, NLR
title_fullStr Construction and validation of a prediction model for early recurrence after catheter ablation in patients with persistent atrial fibrillation based on BNP, Ang Ⅱ, homocysteine, MHR, NLR
title_full_unstemmed Construction and validation of a prediction model for early recurrence after catheter ablation in patients with persistent atrial fibrillation based on BNP, Ang Ⅱ, homocysteine, MHR, NLR
title_short Construction and validation of a prediction model for early recurrence after catheter ablation in patients with persistent atrial fibrillation based on BNP, Ang Ⅱ, homocysteine, MHR, NLR
title_sort construction and validation of a prediction model for early recurrence after catheter ablation in patients with persistent atrial fibrillation based on bnp ang ii homocysteine mhr nlr
topic persistent atrial fibrillation
catheter ablation
early recurrence
prediction models
serum indicators
url https://www.frontiersin.org/articles/10.3389/fcvm.2025.1589351/full
work_keys_str_mv AT yuningchen constructionandvalidationofapredictionmodelforearlyrecurrenceaftercatheterablationinpatientswithpersistentatrialfibrillationbasedonbnpangiihomocysteinemhrnlr
AT guojiansun constructionandvalidationofapredictionmodelforearlyrecurrenceaftercatheterablationinpatientswithpersistentatrialfibrillationbasedonbnpangiihomocysteinemhrnlr
AT zhijunzhu constructionandvalidationofapredictionmodelforearlyrecurrenceaftercatheterablationinpatientswithpersistentatrialfibrillationbasedonbnpangiihomocysteinemhrnlr
AT farongshen constructionandvalidationofapredictionmodelforearlyrecurrenceaftercatheterablationinpatientswithpersistentatrialfibrillationbasedonbnpangiihomocysteinemhrnlr